IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib

HAEMATOLOGICA

Sandova, V; Pavlasova, GM; Seda, V; Cerna, KA; Sharma, S; Palusova, V; Brychtova, Y; Pospisilova, S; Fernandes, SM; Panovska, A; Doubek, M; Davids, MS; Brown, JR; Mayer, J; Mraz, M, 2021: IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib. HAEMATOLOGICA 106(11), p. 2995 - 2999, doi: 10.3324/haematol.2021.278644

Research Groups:

Microenvironment of Immune Cells

CEITEC authors:

Václav Šeda, Ph.D.
Prof. Marek Mráz, Ph.D.